Clinical trial

Stereotactic Transplantation of hAESCs for Parkinson's Disease

NCT04414813

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-10-08

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2020-10-08Date precision: day

Registry last updated2023-04-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson's Diseaseunresolved

Interventions

Human Amniotic Epithelial Stem CellsBIOLOGICAL

Sponsors & collaborators

Shanghai East Hospitallead sponsor

Shanghai iCELL Biotechnology Co., Ltd, Shanghai, Chinacollaborator

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04414813 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.